RAFFA WEALTH MANAGEMENT, LLC’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
BC
CMF
HWAM
ETC
PFSRSONJ
CG
CUAMC
RAFFA WEALTH MANAGEMENT, LLC's NVCR Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC held its NovoCure (NVCR) position steady in Q2 2026 at 16 shares worth $242. The position accounts for ﹤0.01% of the portfolio, ranked #1241.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in NVCR in Q1 2020 and has held it in 24 quarters since. The position peaked at $4.44K in Q2 2021. 37 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 16 shares of NovoCure worth $242 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC left its NovoCure share count unchanged in Q2 2026.
- NovoCure made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1241 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in NovoCure in Q1 2020 and has held it in 24 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's NovoCure position peaked at $4.44K in Q2 2021.
- 37 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.